Journal Article

Tissue plasminogen activator with prolonged dwell time effectively evacuates pleural effusions

Block, Mark I., Raju, Harsha, Tami, Catherine M., Serpa, Krystina A., Tarrazzi, Francisco A., Townsend, Alexandra, Pruett, Rachel, Razi, Syed S.

2022

Overview

Objectives Fibrinolytic therapy can be effective for management of complex pleural effusions. Tissue plasminogen activator (tPA, 10 mg) and deoxyribonuclease (DNAse) every 12 h with a dwell time of one hour is a common strategy based on published data. We used a simpler protocol of tPA (4 mg) without DNAse but with a longer dwell time of 12 h, repeated daily. We reviewed our results. Methods Charts were reviewed and demographics, clinical data and treatment information were abstracted. Outcomes were assessed based on radiographic findings and need for surgery. Results Two hundred and fifteen effusions in 207 patients (8 bilateral) were identified. 85% were either infectious or malignant. Two hundred and forty nine chest tubes were used: 84% were 10 Fr or 12 Fr and 7% were PleurX®. Five hundred and thirty one doses of tPA were given. The median number of doses per effusion was 2 (range 1–10), and 84% of effusions were treated with three or fewer doses. There were no significant bleeding complications. Median time to chest tube removal was 6 days (range 1 to 98, IQR 4 to 10). Drainage was considered complete for 78% of effusions, while 6% required decortication. Conclusions Low dose tPA daily with a 12 h dwell time may be as effective as the standard regimen of tPA and DNAse twice daily with one hour dwell. For most patients only three doses were required, and small pigtail catheters were sufficient. This regimen uses less medication and is logistically much easier than the current standard.

• Publisher: BioMed Central,BioMed Central Ltd,Springer Nature B.V,BMC
• Subject: Analysis / Care and treatment / Catheters / Chest / Chest tubes / Critical Care Medicine / Deoxyribonuclease / Deoxyribonucleases - administration & dosage / Deoxyribonucleases - therapeutic use / Drug Administration Schedule / Effusion / Empyema / Empyema, Pleural - drug therapy / Fibrin / Fibrinolytic Agents - therapeutic use / Fibrinolytic therapy / Hemoglobin / Humans / Intensive / Internal Medicine / Medical records / Medicine / Medicine & Public Health / Parapneumonic effusion / Patients / Pleural effusion / Pleural effusions / Pneumology/Respiratory System / Properties / Pulmonology / Retrospective Studies / Surgery / t-Plasminogen activator / Thrombolytic drugs / Tissue plasminogen activator / Tissue Plasminogen Activator - administration & dosage / Tissue Plasminogen Activator - therapeutic use / tPA